BioMarin Pharmaceutical | Bruttoergebnis Vom Umsatz



Gross Profit On Sales Veränderung Datum
Acadia Pharmaceuticals USD 223.92M 13.87M 2025-03
Agios Pharmaceuticals USD 7.64M 1.83M 2025-03
Alnylam Pharmaceuticals USD 523.15M 32.8M 2025-03
Amgen USD 5.54B 430M 2025-03
Bayer EUR 8.11B 2.11B 2025-03
Biogen USD 1.87B 44.1M 2024-12
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Gilead Sciences USD 5.99B 17M 2024-12
Incyte USD 985.09M 111.22M 2025-03
Insmed USD 71.54M 6.75M 2025-03
Ionis Pharmaceuticals USD 130.15M 92.6M 2025-03
Moderna USD 17M 403M 2025-03
Neurocrine Biosciences USD 618.4M 4.3M 2024-12
PTC Therapeutics USD 196.89M 10.95M 2024-12
Regeneron Pharmaceuticals USD 2.56B 659.4M 2025-03
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 5.36B 4.71B 2024-12
Sarepta Therapeutics USD 607.29M 81.18M 2025-03
Ultragenyx Pharmaceutical USD 110.63M 37.35M 2025-03
United Therapeutics USD 701.9M 41.9M 2025-03
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12



BioMarin Pharmaceutical Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.